Growth Metrics

Moderna (MRNA) Change in Inventory (2020 - 2026)

Moderna (MRNA) has disclosed Change in Inventory for 7 consecutive years, with -$6.0 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Inventory fell 175.0% year-over-year to -$6.0 million; the TTM value through Mar 2026 reached $20.0 million, up 111.9%, while the annual FY2025 figure was $34.0 million, 140.96% up from the prior year.
  • Change in Inventory hit -$6.0 million in Q1 2026 for Moderna, up from -$179.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $501.0 million in Q1 2022 and bottomed at -$1.1 billion in Q4 2022.
  • Average Change in Inventory over 5 years is -$76.1 million, with a median of -$6.0 million recorded in 2026.
  • Year-over-year, Change in Inventory crashed 336.97% in 2022 and then surged 727.27% in 2025.
  • Moderna's Change in Inventory stood at -$1.1 billion in 2022, then skyrocketed by 74.73% to -$285.0 million in 2023, then decreased by 2.11% to -$291.0 million in 2024, then skyrocketed by 38.49% to -$179.0 million in 2025, then soared by 96.65% to -$6.0 million in 2026.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$6.0 million, -$179.0 million, and $91.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.